vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and TSS, Inc. (TSSI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $60.9M, roughly 1.2× TSS, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 21.8%). TSS, Inc. produced more free cash flow last quarter ($15.8M vs $14.4M). Over the past eight quarters, TSS, Inc.'s revenue compounded faster (95.8% CAGR vs 31.3%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
PBYI vs TSSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $60.9M |
| Net Profit | — | $12.2M |
| Gross Margin | 69.3% | 17.6% |
| Operating Margin | 22.7% | 1.5% |
| Net Margin | — | 20.0% |
| Revenue YoY | 27.7% | 21.8% |
| Net Profit YoY | — | 535.7% |
| EPS (diluted) | $0.26 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $60.9M | ||
| Q3 25 | $54.5M | $41.9M | ||
| Q2 25 | $52.4M | $44.0M | ||
| Q1 25 | $46.0M | $99.0M | ||
| Q4 24 | $59.1M | $50.0M | ||
| Q3 24 | $80.5M | $70.1M | ||
| Q2 24 | $47.1M | $12.2M | ||
| Q1 24 | $43.8M | $15.9M |
| Q4 25 | — | $12.2M | ||
| Q3 25 | $8.8M | $-1.5M | ||
| Q2 25 | $5.9M | $1.5M | ||
| Q1 25 | $3.0M | $3.0M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $20.3M | $2.6M | ||
| Q2 24 | $-4.5M | $1.4M | ||
| Q1 24 | $-4.8M | $15.0K |
| Q4 25 | 69.3% | 17.6% | ||
| Q3 25 | 77.7% | 11.1% | ||
| Q2 25 | 76.5% | 17.8% | ||
| Q1 25 | 77.1% | 9.3% | ||
| Q4 24 | 76.4% | 14.4% | ||
| Q3 24 | 63.9% | 11.3% | ||
| Q2 24 | 77.4% | 37.3% | ||
| Q1 24 | 75.5% | 17.1% |
| Q4 25 | 22.7% | 1.5% | ||
| Q3 25 | 17.6% | -2.2% | ||
| Q2 25 | 12.7% | 5.1% | ||
| Q1 25 | 8.7% | 4.2% | ||
| Q4 24 | 22.6% | 0.0% | ||
| Q3 24 | 27.4% | 5.4% | ||
| Q2 24 | -4.6% | 14.0% | ||
| Q1 24 | -5.3% | 1.6% |
| Q4 25 | — | 20.0% | ||
| Q3 25 | 16.2% | -3.6% | ||
| Q2 25 | 11.2% | 3.4% | ||
| Q1 25 | 6.5% | 3.0% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | 25.2% | 3.8% | ||
| Q2 24 | -9.6% | 11.5% | ||
| Q1 24 | -11.0% | 0.1% |
| Q4 25 | $0.26 | $0.44 | ||
| Q3 25 | $0.17 | $-0.06 | ||
| Q2 25 | $0.12 | $0.06 | ||
| Q1 25 | $0.06 | $0.12 | ||
| Q4 24 | $0.40 | $0.08 | ||
| Q3 24 | $0.41 | $0.10 | ||
| Q2 24 | $-0.09 | $0.06 | ||
| Q1 24 | $-0.10 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $85.5M |
| Total DebtLower is stronger | $22.7M | — |
| Stockholders' EquityBook value | $130.3M | $76.6M |
| Total Assets | $216.3M | $184.9M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $85.5M | ||
| Q3 25 | $94.4M | $70.7M | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | $23.2M | ||
| Q3 24 | $96.7M | $46.4M | ||
| Q2 24 | $96.8M | $8.3M | ||
| Q1 24 | $107.2M | $14.4M |
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $76.6M | ||
| Q3 25 | $115.3M | $63.4M | ||
| Q2 25 | $104.7M | $9.5M | ||
| Q1 25 | $97.1M | $9.4M | ||
| Q4 24 | $92.1M | $7.1M | ||
| Q3 24 | $71.1M | $7.7M | ||
| Q2 24 | $48.5M | $5.2M | ||
| Q1 24 | $51.0M | $3.7M |
| Q4 25 | $216.3M | $184.9M | ||
| Q3 25 | $202.9M | $165.4M | ||
| Q2 25 | $194.9M | $139.5M | ||
| Q1 25 | $196.2M | $113.5M | ||
| Q4 24 | $213.3M | $96.6M | ||
| Q3 24 | $220.7M | $67.3M | ||
| Q2 24 | $205.0M | $28.9M | ||
| Q1 24 | $214.1M | $26.8M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $16.3M |
| Free Cash FlowOCF − Capex | $14.4M | $15.8M |
| FCF MarginFCF / Revenue | 19.1% | 25.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $16.3M | ||
| Q3 25 | $9.7M | $-18.4M | ||
| Q2 25 | $14.1M | $16.3M | ||
| Q1 25 | $3.6M | $20.6M | ||
| Q4 24 | $15.6M | $-21.6M | ||
| Q3 24 | $11.0M | $38.6M | ||
| Q2 24 | $1.0M | $-4.3M | ||
| Q1 24 | $11.2M | $2.6M |
| Q4 25 | $14.4M | $15.8M | ||
| Q3 25 | $9.7M | $-24.9M | ||
| Q2 25 | $14.1M | $5.4M | ||
| Q1 25 | $3.6M | $5.8M | ||
| Q4 24 | $15.6M | $-28.4M | ||
| Q3 24 | $11.0M | $38.6M | ||
| Q2 24 | $1.0M | $-6.0M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | 19.1% | 25.9% | ||
| Q3 25 | 17.7% | -59.3% | ||
| Q2 25 | 26.8% | 12.3% | ||
| Q1 25 | 7.7% | 5.8% | ||
| Q4 24 | 26.4% | -56.7% | ||
| Q3 24 | 13.7% | 55.1% | ||
| Q2 24 | 2.1% | -49.4% | ||
| Q1 24 | — | 16.4% |
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 15.3% | ||
| Q2 25 | 0.0% | 24.8% | ||
| Q1 25 | 0.1% | 15.0% | ||
| Q4 24 | 0.0% | 13.4% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | 13.8% | ||
| Q1 24 | 0.0% | 0.2% |
| Q4 25 | — | 1.34× | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | 11.02× | ||
| Q1 25 | 1.21× | 6.93× | ||
| Q4 24 | — | -11.32× | ||
| Q3 24 | 0.54× | 14.60× | ||
| Q2 24 | — | -3.09× | ||
| Q1 24 | — | 176.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |
